Aug 17, 2018   SOURCE: PR NewsWire

Leukapheresis Products & Leukopaks Market Worth $27.7 and $445.6 Million Respectively by 2023

PUNE, India, August 17, 2018 /PRNewswire/ --

According to a new market research report "Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Leukopak (Mobilized, Non-Mobilized, Human Primary Cells), Application (Research, Therapeutic), End User (Hospitals, Research Institute) - Global Forecast to 2023", published by MarketsandMarkets(TM), the market is expected to reach USD 27.7 million by 2023 from an estimated USD 19.4 million in 2018, at a CAGR of 7.4%.

(Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Browse 134 market data Tables and 49 Figures spread through 194 Pages and in-depth TOC on "Leukapheresis Market"

https://www.marketsandmarkets.com/Market-Reports/leukapheresis-market-20283148.html [https://www.marketsandmarkets.com/Market-Reports/leukapheresis-market-20283148.html?utm_source=prnewswire&utm_medium=referral&utm_campaign=paidpr ]

Early buyers will receive 10% customization on this report 

The major factors driving the growth of the market include the rising incidence and prevalence of leukemia, growing demand for leukopaks, and the increasing number of blood donations.

By product, the apheresis devices segment is expected to account for the largest share of the leukapheresis devices market in 2018 

On the basis of type, the Leukapheresis Devices Market is segmented into apheresis devices, leukapheresis columns & cell separators, and leukoreduction filters. In 2017, the apheresis devices segment accounted for the largest share of the Leukapheresis Devices Market. The large share of this segment is attributed to the widespread adoption of apheresis devices for performing therapeutic leukapheresis procedures for the treatment of leukemia and development of leukopaks for clinical and preclinical research.

By product, the mobilized PB leukopaks segment is expected to account for the largest share of the Leukopaks Market in 2018 

On the basis of type, the Leuopaks Market is segmented into mobilized PB leukopaks, non-mobilized PB leukopaks, diseased leukopaks, and isolated PBMCs. The mobilized PB leukopaks segment is expected to account for the largest share of the global Leukopaks Market in 2018. The dominant share of this segment is attributed to the increasing demand for low-granulocyte and low-hematocrit contamination, high cell viability, and an increase in CD34+ cell frequencies for the development of immunotherapies.

Ask for PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=20283148 [https://www.marketsandmarkets.com/pdfdownload.asp?id=20283148&utm_source=prnewswire&utm_medium=referral&utm_campaign=paidpr ]

Asia Pacific to dominate the market in 2018 

Asia Pacific is expected to account for the largest share of the Leukapheresis Market in 2018, followed by North America. The increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the presence of leading pharma and biotech companies focusing on cell therapy research are factors are driving the growth of this regional segment.

The prominent players in the global Leukapheresis Products Market are Asahi Kasei Medical (Japan), Fresenius (Germany), Haemonetics Corporation (US), Terumo BCT (US), STEMCELL Technologies (Canada), and Macopharma (France).

Some prominent players in the Leukopaks Market are HemaCare (US), AllCells (US), StemExpress (US), PPA Research Group (US), Key Biologics (US), Caltag Medsystem (UK), ZenBio (US), Precision for Medicine (US), and BioIVT (US).

Know more about the Leukapheresis Market: 

https://www.marketsandmarkets.com/Market-Reports/leukapheresis-market-20283148.html [https://www.marketsandmarkets.com/Market-Reports/leukapheresis-market-20283148.html?utm_source=prnewswire&utm_medium=referral&utm_campaign=paidpr ]

About MarketsandMarkets(TM)  

MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. 

            Contact: 
        Mr. Shelly Singh 
        MarketsandMarkets(TM) INC. 
        630 Dundee Road 
        Suite 430 
        Northbrook, IL 60062 
        USA: +1-888-600-6441 
        Email: sales@marketsandmarkets.com

 

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/leukapheresis-market.asp

Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets 


    Photo: 
    https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

SOURCE MarketsandMarkets